The struggling Santa Barbara Neighborhood Clinics nonprofit is narrowing its funding gap and has a strategic plan and new permanent CEO in place, putting it on track to become financially sustainable at a time when it looks to expand service to Goleta.
“Six months ago, we were in danger of closing our doors,” said Mark Palmer, president of the board.
The findings highlight a pervasive mismatch between the high price of even starter homes and the number of jobs that pay wages high enough to support those prices. Experts say the gap is a significant roadblock to the state’s economic growth.
Shale Oak Winery’s tasting room in Paso Robles is one of the more eye-catching in the area with its colorful, angular facade of stained glass in a geometric pattern.
Business and agriculture leaders speaking at a Nov. 8 economic forecast hosted by the California Lutheran University Center for Economic Research and Forecasting put forth a vocal call for immigration reform amid a deepening farm-labor shortage.
The $1.6 billion Westlake Village-based digital advertising company has been under fire from investors — and trial attorneys — for its reliance acquisitions to produce revenue growth. It has also faced criticism of the steep losses it has taken on selling off business lines that didn’t work out.
Thousand Oaks-based ImmunGene, a cancer treatment firm led by a former Amgen scientist, has raised $9 million from Ally Bridge Group, an investment group with ties to Hong Kong.
ImmunGene’s so-called antibody-cytokine fusion technology could help improve the cancer-cell targeting in therapies. President and CEO Sanjay D. Khare was formerly the scientific director at Amgen, the biotech giant. Prior to the funding, ImmunGene had received several hundred thousand dollars in federal research grants.